(5R)-5-hydroxytriptolide inhibits the inflammatory cascade reaction in astrocytes.
Ontology highlight
ABSTRACT: Many studies have shown that (5R)-5-hydroxytriptolide is the optimal modified analogue of triptolide, possessing comparable immunosuppressive activity but much lower cytotoxicity than triptolide. Whether (5R)-5-hydroxytriptolide has preventive effects on neuroinflammation is unclear. This study was designed to pretreat primary astrocytes from the brains of neonatal Sprague-Dawley rats with 20, 100 and 500 nM (5R)-5-hydroxytriptolide for 1 hour before establishing an in vitro neuroinflammation model with 1.0 ?g/mL lipopolysaccharide for 24 hours. The generation of nitric oxide was detected by Griess reagents. Astrocyte marker glial fibrillary acidic protein was measured by immunohistochemical staining. The levels of tumor necrosis factor-? and interleukin-1? in the culture supernatant were assayed by enzyme linked immunosorbent assay. Nuclear factor-?B/p65 expression was examined by immunofluorescence staining. The phosphorylation of inhibitor of nuclear factor I?B-? and the location of nuclear factor-?B/P65 were determined using western blot assay. Our data revealed that (5R)-5-hydroxytriptolide inhibited the generation of nitric oxide, tumor necrosis factor-? and interleukin-1? from primary astrocytes activated by lipopolysaccharide, decreased the positive reaction intensity of glial fibrillary acidic protein, reduced the expression of tumor necrosis factor alpha and interleukin-1? in culture supernatant, inhibited the phosphorylation of I?B-? and the translocation of nuclear factor-?B/P65 to the nucleus. These results have confirmed that (5R)-5-hydroxytriptolide inhibits lipopolysaccharide-induced glial inflammatory response and provides cytological experimental data for (5R)-5-hydroxytriptolide in the treatment of neurodegenerative diseases.
SUBMITTER: Cui YQ
PROVIDER: S-EPMC6375032 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
ACCESS DATA